CONCERT: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind Twelve-Month Safety and Efficacy Study evaluating Dimebon in Patients with Mild-to-moderate Alzheimer Disease on Donepezil (2009-2011)
Experts
Professor
Gerard Byrne
Mayne Professor of Psychiatry
Medical School
Faculty of Health, Medicine and Behavioural Sciences
